If eligible, receive a clinically developed and FDA-approved weight loss and prescription medication plan, insurance coordination, and ongoing support
Common: Nausea, vomiting, diarrhea, or constipation Reduced appetite (sometimes too much) Mild low blood sugar (especially with other diabetes medications) Injection site reactions Less common but serious: Pancreatitis Gallbladder issues Kidney complications from dehydration Thyroid tumors (observed in rodent studies and still under investigation in humans) This is a non-exhaustive list
Alcohol use and poor sleep quality: A longitudinal twin study across 36 years
Some patients may also benefit from blood work or muscle mass screening before starting a GLP-1
Future directions and innovation opportunities: Standardize scaffold materials and degradation profiles for predictable retention
[18] also reported that preoperative semaglutide use within 10 days of elective surgery was independently associated with increased residual gastric content, as assessed by gastric ultrasound
